Assessment of Sleep and Sleep Disruptors in Adolescents With Type 1 Diabetes
- Conditions
- Insufficient SleepType 1 Diabetes
- Registration Number
- NCT05370339
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
The goal of this study is to identify causes of insufficient sleep and sleep disruptors in adolescents with type 1 diabetes. For this study, adolescents will wear an actigraphy watch and complete sleep diaries for seven days. On completion of the seven days, they will complete several questionnaires regarding sleep, fear of hypoglycemia, and anxiety and depression. A subset of participants will additionally complete a qualitative interview session to obtain a deeper understanding of sleep disruptors and barriers and facilitators to improving sleep health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- Diagnosed with T1D at least 3 months
- Receive clinical care at the Barbara Davis Center
- Have an active underlying sleep disorder, such as narcolepsy, insomnia, or untreated sleep apnea
- Participation in an interventional research protocol
- Unable to complete study procedures
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of nocturnal awakenings per week One week per participant We will identify the number of nocturnal awakenings per week for comparison of those with insufficient sleep identified by actigraphy watch to those with sufficient sleep.
Assessment of facilitators and barriers to good sleep quality and duration One week per participant Qualitative interviews will be conducted and analyzed for themes to identify causes of sleep disruptions and any potential barriers or facilitators to improving sleep health.
- Secondary Outcome Measures
Name Time Method Identification of common causes of sleep disruptors in adolescents with type 1 diabetes One week per participant Sleep diaries will be used to determine common causes of sleep disruptors in adolescents with type 1 diabetes.
Trial Locations
- Locations (1)
University of Colorado, Barbara Davis Center
🇺🇸Aurora, Colorado, United States